Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation

Oncogene

Volumn 23, Issue 35, 2004, Pages 6006-6011

  Carnero, Amancio ^a   Beach, David H ^b  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

c myc; Oncogenic cooperation; PI3k; Ras; Waf1

Indexed keywords

MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P21; RAS PROTEIN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; EMBRYO; EMBRYO (ANATOMY); FIBROBLAST; GENE EXPRESSION; GENE INACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; LIFESPAN; MOUSE; NONHUMAN; NULL CELL; ONCOGENE RAS; PRIORITY JOURNAL; SENESCENCE; TUMOR SUPPRESSOR GENE; ANIMAL; CELL AGING; NEOPLASM; ONCOGENE MYC; PHYSIOLOGY;

ANIMALIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL AGING; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENES, MYC; GENES, RAS; MICE; NEOPLASMS;

EID: 4043171390     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207839     Document Type: Article

References (42)

1. Amati B, Alevizopoulos K and Vlach J. (1998). Front Biosci., 3, D250-D268.
2. Brugarolas J, Bronson RT and Jacks T. (1998). J. Cell. Biol., 141, 503-514.
3. Carnero A, Hudson JD, Hannon GJ and Beach DH. (2000). Nucleic Acids Res., 28, 2234-2241.
4. Ceballos E, Delgado MD, Gutierrez P, Richard C, Muller D, Eilers M, Ehinger M, Gullberg U and Leon J. (2000). Oncogene, 19, 2194-2204.
5. Franza Jr BR, Maruyama K, Garrels JI and Ruley HE. (1996). Cell, 44, 409-118.
6. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A and Donehower LA. (1993). Oncogene, 8, 2457-2467.
7. Henriksson M and Luscher B. (1996). Adv. Cancer Res., 68, 109-182.
8. Hunter T. (1991). Cell, 64, 249-270.
9. Jansen-Dürr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G and Eilers M. (1993). Proc. Natl. Acad. Sci. USA, 90, 3685-3689.
10. Jones JM, Cui XS, Medina D and Donehower LA. (1999). Cell Growth Differ., 10, 213-222.
11. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ. (1997). Cell, 91, 649-659.
12. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J and Evan G. (1997). Nature, 385, 544-548.
13. Land H, Chen AC, Morgenstern JP, Parada LF and Weinberg RA. (1986). Mol. Cell. Biol., 6, 1917-1925.
14. Langdon WY, Harris AW and Cory S. (1989). Oncogene Res., 4, 253-258.
15. Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, Martin-Caballero J, Flores JM, Cordon-Cardo C and Barbacid M. (2000). EMBO J., 19, 3496-3506.
16. Leone G, DeGregori J, Sears R, Jakoi L and Nevins JR. (1997). Nature, 387, 422-426.
17. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M and Lowe SW. (1998). Genes Dev., 12, 3008-3019.
18. Martin-Caballero J. Flores JM, Garcia-Palencia P and Serrano M. (2001). Cancer Res., 61, 6234-6238.
19. Micheli P, Li W, Lorenzi MW, Miki T, Zakut R, Givol D and Pierce JH. (1996). Oncogene, 12, 775-784.
20. Missero C, Di Cunto F, Kiyokawa H, Koff A and Dotto GP. (1996). Genes Dev., 10, 3065-3075.
21. Newbold RF and Overell RW. (1983). Nature, 304, 648-651.
22. Palmero I, Pantoja C and Serrano M. (1998). Nature, 395, 125-126.
23. Pantoja C and Serrano M. (1999). Oncogene, 18, 4974-4982.
24. Parada LF, Land H, Weinberg RA, Wolf D and Rotter V. (1984). Nature, 312, 649-651.
25. Perez-Roger I, Solomon DLC, Sewing A and Land H. (1997). Oncogene, 14, 2373-2381.
26. Philipp J, Vo K, Gurley KE, Seidel K and Kemp CJ. (1999). Oncogene, 18, 4689-4698.
27. Rudolph B, Saffrich R, Zwicker J, Henglein B, Müller R, Ansorge W and Eilers M. (1996). EMBO J., 15, 3065-3076.
28. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW. (1997). Cell, 88, 593-602.
29. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R and Leder P. (1987). Cell, 49, 465-475.
30. Spencer CA and Groudine M. (1991). Adv. Cancer Res., 56, 1-48.
31. Steiner P, Philipp A, Lukas J, Godden-Kent D, Pagano M, Mittnacht S, Bartek J and Eilers M. (1995). EMBO J., 14, 4814-4826.
32. Thompson TC, Southgate J, Kitchener G and Land H. (1989). Cell, 56, 917-930.
33. Topley GI, Okuyama R, Gonzales JG, Conti C and Dotto GP. (1999). Proc. Natl. Acad. Sci. USA, 96, 9089-9094.
34. Tsuneoka M and Mekada E. (2000). Oncogene, 19, 115-123.
35. Vlach J, Hennecke S, Alevizopoulos K, Conti D and Amati B. (1996). EMBO J., 15, 6595-6604.
36. Vogelstein B and Kinzler KW. (1993). Trends Genet., 9, 138-141.
37. Wagner AJ, Kokontis JM and Hay N. (1994). Genes Dev., 8, 2817-2830.
38. Weinberg RA. (1989). Cancer Res., 49, 3713-3721.
39. Weinberg WC, Azzoli CG, Chapman K, Levine AJ and Yuspa SH. (1995). Oncogene, 10, 2271-9227.
40. Weinberg WC, Fernandez-Salas E, Morgan DL, Shalizi A, Mirosh E, Stanulis E, Deng C, Henning SH and Yuspa SH. (1999). Cancer Res., 59, 2050-2054.
41. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, Eilers M, Leon J and Larsson LG. (2003). Oncogene, 22, 351-360.
42. Zhu J, Woods D, McMahon M and Bishop JM. (1998). Genes Dev., 12, 2997-3007.